X0508 4 2025-01-01 0 0001534120 Avalo Therapeutics, Inc. AVTX 0002047607 Riley Jennifer C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 0 1 0 0 Chief Strategy Officer 0 Stock Option (Right to Buy) 7.43 2025-01-01 4 A 0 150000 0 A 2035-01-01 Common Stock 150000 150000 D Twenty-five percent (25%) of the Option Shares vest on January 1, 2026 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date. /s/ Donald R. Reynolds, by Power of Attorney 2025-01-03